
Cigna Corporation CI
$ 284.07
0.08%
Annual report 2025
added 02-26-2026
Cigna Corporation DIO Ratio 2011-2026 | CI
Annual DIO Ratio Cigna Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 | 12.3 | 14.2 | 12.4 | 10.7 | 10.3 | 10.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.2 | 10.2 | 11.7 |
Quarterly DIO Ratio Cigna Corporation
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 | 13 | - | 5.77 | 5.13 | 11.1 | - | 9.2 | 9.38 | 10.2 | - | 10.8 | 11.3 | 11 | - | 9.89 | 9.73 | 10.4 | - | 428 | 420 | 248 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 428 | 5.13 | 72.6 |
DIO Ratio of other stocks in the Health care industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Magellan Health, Inc.
MGLN
|
3.55 | - | -0.19 % | $ 2.49 B | ||
|
CVS Health Corporation
CVS
|
30.8 | $ 80.14 | -0.45 % | $ 102 B | ||
|
NovoCure Limited
NVCR
|
83.3 | $ 13.3 | - | $ 1.48 B | ||
|
UnitedHealth Group Inc.
UNH
|
25.6 | $ 291.41 | 0.76 % | $ 265 B |